Kora Healthcare Team2025-09-29T12:12:44+01:00September 29th, 2025|
Kora Healthcare is pleased to have completed the NHS Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in Kora Healthcare receiving a Level 2: Comprehensive net zero targets and reporting for carbon emissions. This is key to supporting us
Kora Healthcare Team2025-09-29T12:11:15+01:00September 29th, 2025|
Kora Healthcare is proud to launch our 2024 NHS Carbon Reduction Plan, developed in partnership with Nocomed, a leading life sciences sustainability platform. This strategic initiative underscores our commitment to environmental sustainability, corporate transparency, and data-driven climate action. Key Carbon Emission Reductions (2023–2024): ✅ Scope
Kora Healthcare Team2025-09-29T11:48:21+01:00September 29th, 2025|
We’re thrilled to announce that our sister compnay Arok Healthcare has officially received EU MDR (European Union Medical Device Regulation) certification for our trusted medical device products—Relactagel and Regelle. This regulatory approval marks a major achievement in our commitment to delivering safe, effective, and compliant
Kora Healthcare Team2025-09-29T12:02:25+01:00March 10th, 2025|
Kora Healthcare is pleased to have completed the NHS Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in us receiving a Level 1: Publicly committed to net zero carbon and engaged with sustainability. The information reported through Evergreen is
Kora Healthcare Team2022-01-24T10:23:59+00:00January 24th, 2022|
SELENASE - KORA HEALTHCARE APPOINTED SELENASE MARKETING AUTHORISATION HOLDER Dublin, Ireland, 24 January 2022. Biosyn Arzneimittel GmbH and Kora Healthcare concluded an exclusive licensing agreement for the continued supply and commercialisation of selenase ® (sodium selenite pentahydrate) in the United Kingdom for the treatment of
Kora Healthcare Team2021-10-04T16:07:19+01:00October 4th, 2021|
Kora Healthcare, an emerging Dublin-based pharma company, today announced it has acquired Chifam Inc, a Canadian-based speciality pharma company focussed on immunotherapy and immune modulation. The acquisition of Chifam Inc by Kora Healthcare is via its Canadian entity Kora Healthcare Canada Inc. No deal terms
Kora Healthcare Team2021-05-04T15:07:06+01:00May 4th, 2021|
Kora Healthcare are delighted to be announced as Winner of the Exporter of the Year award in the SFA National Small Business Awards 2021! The SFA Awards celebrate the achievements of small businesses in Ireland and recognises the important and vital contributions of this sector
lydia2018-09-28T09:36:26+01:00September 28th, 2018|
Kora Healthcare are currently recruiting for a Quality Officer to join our Quality Department. APPLY HERE We are an emerging company committed to identifying, developing and commercialising healthcare products internationally across a spectrum of therapeutic areas. We are dedicated to delivering high quality
lydia2018-05-31T09:53:47+01:00May 25th, 2018|
Kora Healthcare at ICGP AGM We are delighted to be exhibiting at the ICGP Annual Conference at the Convention centre Dublin this weekend. The Irish College of General Practitioners Annual Conference and AGM is the largest gathering of GPs in Ireland. The theme of this years
lydia2018-05-31T09:33:39+01:00May 3rd, 2018|
Kora Healthcare welcomes Jude Ngadaonye to the role of Development Specialist. - Kora Careers News We are delighted to welcome Jude Ngadaonye, who has joined the team as Development Specialist, working within our R&D Department. As a post-doctoral researcher, Jude most recently worked in the Bernal
